Santiago Arroyo - 07 Nov 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Reporting relationship: Chief Medical Officer
Issuer ticker: FULC
Reported as of: 07 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Nov 2022, 15:15:14 UTC
Prior SEC filing: 07 Feb 2022
Next SEC filing: 04 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Greg Tourangeau, as attorney-in-fact for Santiago Arroyo

Key filing fact

Santiago Arroyo filed Form 4 for Fulcrum Therapeutics, Inc. (FULC) on 09 Nov 2022.

Key facts

This page summarizes Santiago Arroyo's Form 4 filing for Fulcrum Therapeutics, Inc. (FULC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Nov 2022, 15:15.

Change

Previous filing in this sequence was filed on 07 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FULC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +400,000
Change %
Price: $0.000000
Shares after: 400,000
Date: 07 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $5.61
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on November 7, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of November 7, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.